CRT 2026

CRT PREDICTS | CHIP-BCIS3

Moderator(s)

• 

  Gregg W. Stone, MD, FACC, MSCAI

  Physician
  Mount Sinai
  New York, New York, United States

  Disclosure(s): Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)

Panel Discussant(s)

• 

  Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI

  Professor of Medicine
  New York University School of Medicine
  New York University School of Medicine
  New York, New York, United States

  Disclosure(s): Abbott Vascular, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Jupiter Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Stryker: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  David Cox, MD, MSCAI

  Interventional Cardiologist
  Sanger HVI Charlotte NC
  Charlotte, North Carolina, United States

  Disclosure information not submitted.
• 

  John M. Lasala, MD, PhD, MSCAI

  Professor of Medicine; Director, Structural Heart Disease Program
  Washington University School of Medicine
  St. Louis, Missouri, United States

  Disclosure information not submitted.
• 

  Jeffrey W. Moses, MD, FSCAI

  John and Myrna Daniels Professor of Cardiology
  Columbia University Medical Center
  New York, New York, United States

  Disclosure information not submitted.
• 

  David G. Rizik, MD, MSCAI, FACC

  Chief Scientific Officer, Chief of Complex Interventional Cardiology, Director of Structural & Coronary Intervention, Interventional Cardiology Fellowship Program Director
  HonorHealth, Scottsdale Arizona
  Scottsdale, Arizona, United States

  Disclosure information not submitted.